Оптимизация стратегии ведения пациентОв при стабильнОй стенОкардии

Cardiovascular diseases are the leading cause of morbidity and mortality in developed countries. Current treatment of stable coronary artery disease is the appointment optimal medical therapy, which in some patients may be supplemented by revascularization in the form of coronary artery bypass grafting or percutaneous coronary intervention. According to the recommendations of the leading cardiology and cardiac surgery communities, revascularization is justified when it is expected a positive effect on quality of life (symptoms, functional status, etc.), as well as against the forecast exceeds the expected adverse effects of this procedure. Myocardial revascularization has gained great popularity in the clinical practice of recent decades, but the long-term results in the evaluation of